Hepatitis D virus infection - Not a vanishing disease in Europe! [3]

Hepatology

Volumn 45, Issue 5, 2007, Pages 1331-1332

  Wedemeyer, Heiner ^a   Heidrich, Benjamin ^a   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; NUCLEOSIDE ANALOG; PEGINTERFERON; PEGINTERFERON ALPHA; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

CLINICAL TRIAL; DELTA AGENT HEPATITIS; EUROPE; GERMANY; HEPATITIS B; HEPATITIS DELTA VIRUS; HUMAN; LETTER; LIVER TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL;

EUROPE; HEPATITIS ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS D, CHRONIC; HEPATITIS DELTA VIRUS; HUMANS; RNA, VIRAL;

EID: 34248647633     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21590     Document Type: Letter

References (10)

1. Niro GA, Ciancio A, Gaeta GB, Smedile A, Marrone A, Olivero A, et al. Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. HEPATOLOGY 2006;44:713-720.
2. Castelnau C, Le Gal F, Ripault MP, Gordien E, Martinot-Peignoux M, Boyet N, et al. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. HEPATOLOGY 2006;44:728-735.
3. Farci P. Treatment of chronic hepatitis D: New advances, old challenges. HEPATOLOGY 2006;44:536-539.
4. Rosina F, Conoscitore P, Cuppone R, Rocca G, Giuliani A, Cozzolongo R, et al. Changing pattern of chronic hepatitis D in Southern Europe. Gastroenterology 1999;117:161-166.
5. Niro GA, Ciancio A, Tillman HL, Lagget M, Olivero A, Perri F, et al. Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study. Aliment Pharmacol Ther 2005;22:227-232.
6. Yurdaydin C, Bozkaya H, Gurel S, Tillmann HL, Asian N, Okcu-Heper A, et al. Famciclovir treatment of chronic delta hepatitis. J Hepatol 2002; 37:266-271.
7. Yutdaydin C, Bozkaya H, Cetinkaya H, Sahin T, Karaoguz D, Toruner M, et al. Lamivudine vs lamivudine and interferon combination treatment of HBeAg(-) chronic hepatitis B. J Viral Hepat 2005;12:262-268.
8. Nito GA, Rosina F, Rizzetto M. Treatment of hepatitis D. J Viral Hepat 2005;12:2-9.
9. Erhardt A, Gerlich W, Starke C, Wend U, Donner A, Sagir A, et al. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. Liver Int 2006;26:805-810.
10. Yurdaydin C, Wedemeyer H, Dalekos GN, Erhardt A, Cakaloglu Y, Degertekin H, et al. A Multicenter Randomised Study Comparing tfie Efficacy of Pegylated interferon-alfa-2a plus Adefovir dipivoxil vs. Pegylated interferon-alfa-2a plus Placebo vs. Adefovir dipivoxil: HEP-NET/Intetnational Delta Hepatitis Intervention Trial (HIDIT-1). HEPATOLOGY 2006;44:230A.